Home » Topics » BioWorld Science

BioWorld Science
RSS

Paratek opens phase IIb study of Nuzyra in M. abscessus pulmonary disease

June 17, 2021

Switching on prodrugs with radiotherapy shows promise

June 17, 2021

Second patient dosed in phase I/II MARVEL-1 study of FLT-190 in Fabry disease

June 17, 2021

Preclinical data for NVG-111: a ROR1xCD3 bispecific antibody

June 17, 2021

Japansese researchers describe new delta-opioid receptor agonists

June 17, 2021

Dunad Therapeutics and 2692372 Ontario, Inc. patent compounds for cancer

June 17, 2021

Janssen Pharmaceutica presents new Mcl-1 inhibitors

June 17, 2021

VenatoRx Pharmaceuticals synthesizes new carbapenem derivatives

June 17, 2021

Infex Therapeutics discloses new antibacterials

June 17, 2021

SpringWorks initiates phase I/II study of mirdametinib in children and young adults with LGG

June 17, 2021

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...